Table 2.
Study [Ref] | Participants/design | Exposures/outcomes | Findings |
---|---|---|---|
MH Tabert, JJ Manly, X Liu, GH Pelton, S Rosenblum, M Jacobs, D Zamora, M Goodkind, K Bell, Y Stern, DP Devanand (2006) Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. [7] | 148 patients reporting memory problems and 63 group-matched controls. Patients were followed up semiannually and controls annually | Subtypes of MCI were determined by using demographically adjusted regression norms on neuropsychological tests. Survival analysis was used to identify the most predictive neuropsychological measures. The outcome was a consensus diagnosis of probable AD | At baseline, 108 patients met criteria for amnestic MCI: 87 had memory plus other cognitive domain deficits and 21 had pure memory deficits. The mean duration of follow-up for the 148 patients was 46.6 ± 24.6 months. In 3 years, 32 (50.0%) of 64 amnestic-“plus” and 2 (10.0%) of 20 “pure” amnestic patients converted to AD (p = 0.001). In 148 patients, of 5 a priori predictors, the percent savings from immediate to delayed recall on the SRT and the WAIS-R Digit Symbol were the strongest predictors of time to conversion. From the entire neuropsychological test battery, a stepwise selection procedure retained 2 measures in the final model: total immediate recall on the SRT (OR per 1-point decrease, 1.10; 95% CI, 1.05–1.14; p = 0.0001) and WAIS-R Digit Symbol coding (OR, 1.06; 95% CI, 1.01–1.11; p = 0.01). The combined predictive accuracy of these 2 measures for conversion by 3 years was 86% |
DP Devanand, G Pradhaban, X Liu, A Khandji, S DeSanti, Segal, H Rusinek, GH Pelton, LS Honig, R Mayeux, Y Stern, MH Tabert, MJ de Leon (2007) Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. [9] | Baseline brain MRI was done in 139 patients with MCI, broadly defined, and 63 healthy controls followed for an average of 5 years (range 1 to 9 years) | Exposures: Hippocampal and entorhinal cortex volumes from brain MRI. Outcomes: Conversion to AD | Hippocampal and entorhinal cortex volumes were each largest in controls, intermediate in MCI non-converters, and smallest in MCI converters to AD (37 of 139 patients converted to AD). In separate Cox proportional hazards models, covarying for intracranial volume, smaller hippocampal volume (RR 3.62, 95% CI 1.93, 6.80, p < 0.0001) and entorhinal cortex volume (RR 2.43, 95% CI 1.56, 3.79, p < 0.0001) each predicted time to conversion to AD. Similar results were obtained for hippocampal and entorhinal cortex volume in patients with MCI with MMSE ≥27/30 (21% converted to AD), and in the subset of patients with amnestic MCI (35% converted to AD). In the total patient sample, when both hippocampal and entorhinal volume were entered into an age-stratified Cox model with gender, MMSE, education, and intracranial volume, smaller hippocampal volume (RR 2.21, 95% CI 1.14, 4.29, p < 0.02) and entorhinal cortex volume (RR 2.48, 95% CI 1.54, 3.97, p < 0.0002) predicted time to conversion to AD. Similar results were obtained in a Cox model that also included SRT delayed recall and WAIS-R Digit Symbol as predictors. Based on logistic regression models in the 3-year follow-up sample, for a fixed specificity of 80%, the sensitivities for MCI conversion to AD were as follows: age 43.3%, MMSE 43.3%, age + MMSE 63.7%, age + MMSE + SRT delayed recall + WAIS-R Digit Symbol 80.6% (79.6% correctly classified), hippocampus + entorhinal cortex 66.7%, age + MMSE + hippocampus + entorhinal cortex 76.7% (85% correctly classified), age + MMSE + SRT delayed recall + WAIS-R Digit Symbol + hippocampus + entorhinal cortex 83.3% (86.8% correctly classified) |
AD, Alzheimer’s disease; MCI, mild cognitive impairment; MMSE, Mini-Mental Status Exam; MRI, magnetic resonance imaging; OR, odds ratio; RR, risk ratio; SRT, Selective Reminding Test; WAIS-R Digit Symbol, Wechsler Adult Intelligence Scale–Revised Digit Symbol Test.